CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 286 enrolled
Drug / intervention
Dapsone plus Adapalene +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01231334
NCT01231334Phase 4Completed
CompareCT.gov

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Allergan·interventional·Posted Nov 1, 2010·Updated Jul 27, 2012

In Brief

A Phase 4 clinical trial evaluating Dapsone plus Adapalene and Clindamycin/benzoyl peroxide plus Adapalene for Acne Vulgaris. Completed, enrolled 286 participants across 1 site.

Detailed Summary

A study comparing the topical application of Aczone® plus Differin® versus Duac® plus Differin® in patients with severe facial acne (facial acne vulgaris).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 1, 2010
Enrollment StartAug 1, 2010
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.7 years ago

Interventions

Dapsone plus Adapalenedrug

Dapsone (Aczone® Gel 5%) applied to entire face in the morning. Adapalene (Differin® 0.3% Gel)followed by Dapsone (Aczone® Gel 5%) applied to entire face in the evening. Daily treatment for 12 weeks.

Clindamycin/benzoyl peroxide plus Adapalenedrug

Clindamycin/benzoyl peroxide (Duac® Topical Gel)applied to entire face in the morning. Adapalene (Differin® 0.3% Gel) applied to entire face in the evening. Daily treatment for 12 weeks